Pricing

IVERIC bio Inc (ISEE)

followers ·
Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Glenn P. Sblendorio
Employees:
90
8 SYLVAN WAY, PARSIPPANY, NJ, 07054
(609) 474-6755

Are you looking for this stock instead?

IVERIC bio, Inc. discovers and develops novel treatments for retinal diseases. Zimura, an inhibitor of complement factor C5, is in Phase 3 clinical trial for the treatment of geographic atrophy (GA) secondary to dry age-related macular degeneration (AMD) The company was incorporated in 2007 and is based in Parsippany, New Jersey.
All 13F Filers Prior Change Hedge Funds 1 Prior Change
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available